参考文献/References:
[1] Angelidis C,Deftereos S,Giannopoulos G,et al.Cystatin C: an emerging biomarker in cardiovascular disease[J].Curr Top Med Chem,2013,13(2):164-179.
[2] Yang B,Zhu JT,Miao ZG,et al.Cystatin C is all Independent risk factor and therapeutic target for acute ischemic stroke[J].Neurotox Res,2015,28(1):1-7.
[3] Fan J,Salameh H.Impact of chronic kidney disease on risk for vascular events[J].Curr Vasc Pharmacol,2016,14(5):409-414.
[4] Abdallah E,Waked E,Al-Helal B,et al.Novel troponin-like biomarkers of acute kidney injury[J].Saudi J Kidney Dis Transpl,2013,24(6):1111-1124.
[5] Salgado JV,Souza FL,Salgado BJ.How to understand the association between cystatin C level and cardiovascular disease:imblance,counterbalance,or consequence?[J].J Cardiol,2013,62(6):331-335.
[6] Xu Y,Ding Y,Li X,et al.Cystatin C is a disease-associated protein subject to multiple regulation[J].Immunol Cell Biol,2015,93(5):442-451.
[7] Zhang J,Wu X,Gao P,et al.Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome[J].BMC Cardiovascular Disorders,2017,17(1):47.
[8] Longenecker CT,Hileman CO,Funderburg NT,et al.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial[J].Clin Infect Dis,2014,59(8):1148-1156.
[9] Nosaka K,Nakamura K,Kusano K,et al.Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction[J].Congest Heart Fail,2013,19(4):E35-E39.
[10] Helmersson-Karlqvist J, Larsson A, Carlsson AC,et al.Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort[J].Atherosclerosis,2014,234(1):108-113.
[11] Li W,Sultana N,Siraj N,et al.Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis[J].J Cell Mol Med,2016,20(9):1664-1672.
[12] Staun-Ram E,Miller A.Cathepsins(S and B)and their inhibitor Cystatin C in immune cells: Modulation by interferon-beta and role played in cell migration[J].J Neuroimmunol,2011,232(1/2):200-206.
[13] Xu Y,Lindemann P,Vega-Ramos J,et al.Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system[J].J Biol Chem,2014,289(14):9730-9740.
[14] Kobayashi T, Yokokawa H, Naito T, et al. Association between high cystatin C Levels and carotid atherosclerosis[J]. World J Cardiol, 2017,9(2):174-181.
[15] Matsumoto A, Yamamoto H, Matsuoka T, et al. Cystatin C-Adiponectin complex in plasma associates with coronary plaque instability[J].2017,24(9):970-979.
[16] Ganda A, Magnusson M, Yvan-Charvet L, et al.Mildrenal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis[J].Circulation,2013,127(9):988-996.
[17] Wen Y, Xia D, Wang Y,et al.Cystatin C is Associated With Plaque Phenotype and Plaque Burden[J].Kidney Blood Press Res,2016,41(2):197-207.
[18] Zhu Y,Zhang HP,Wang YC,et al.Serum cystatin C level is associated with carotid intima-media thickening and plaque[J].Scand J Clin Lab Invest,2015,75(3):265-272.
[19] Umemura T,Kawamura T,Mashita S,et al.Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke[J].Cerebrovasc Dis Extra,2016,6(1):1-11.
[20] Zeng Q, Lin K, Yao M, et al.Significant correlation between cystatin C,cerebral infarction,and potential biomarker for increased risk of stroke[J].Curr Neurovasc Res,2015,12(1):40-46.
[21] Zhang HM,Du DY,Shi YC,et al.The interrelation between the serum cystatin C and cerebral artery stenosis in patiens with cerebral ischemic stroke[J].Journal of Apoplexy and Nervous Diseases,2017,34(6):491-493.
[22] Nah J,Yuan J, Jung YK.Autophagy in neurodegenerative diseases:from mechanism to therapeutic approach[J].Mol Cells,2015,38(5):381-389.
[23] Lin TK,Chen SD,Chuang YC,et al.Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy[J].Int J Mol Sci,2014,15(1):1625-1646.
[24] Fang Z,Deng J,Wu Z,et al.Cystatin C is a crucial endoge-nous protective determinant against stroke[J].Stroke,2017,48(2):436-444.
[25] Liu Y,Li J,Wang Z,et al.Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhagesecondary to Cystatin C:possible involvement of the autophagy pathway[J].Mol Neurobiol,2014,49(2):1043-1054.
[26] Watanabe S,Hayakawa T,Wakasugi K,et al.Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity[J].Cell Death Dis,2014,5(10):e1497.
[27] Gómez M,Vila J,Elosua R,et al.Relationship of lipid oxidation with subclinical atherosclemsis and 10-year comnary events in general population[J].Atherosclerosis,2014,232(1):134-140.
[28] Zhang JB,Jü XH,Wang J,et al.Serum cystatin C and cerebral microbleeds in patients with acute cerebral stroke[J].Journal of Clinical Neuroscience,2014,21(2):268-273.
[29] Hojs Fabjan T, Penko M,Hojs R.Cystatin C,creatinine,estimated glomerular filtration,and long-term mortality in stroke patients[J].Ren Fail,2014,36(1):81-86.